IL-33/ST2信号通过调节替代激活的巨细胞的两极分化来促进瘤的生长

Liping Liu1, Haoge Luo1, Yingdong Xie1

  • 1Key Laboratory of Pathobiology, Ministry of Education, Department of Immunology, College of Basic Medical Sciences, Jilin University, Changchun 130021, China.

PubMed
概括

抑制瘤发生性2 (ST2) 受体与侵袭性非小细胞肺癌 (NSCLC) 的生长有关. 向巨细胞中的IL-33/ST2通路可能为NSCLC提供新的免疫疗法策略.